ClearLight Biotechnologies, LLC — Form D
ClearLight Biotechnologies, LLC of SUNNYVALE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-14. The offering totals $3.2M, of which $2.8M was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-12-14
- Form: D
- Accession: 0001656367-18-000008
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.2M
- Amount sold: $2.8M
- Remaining: $388K
- Minimum investment: $1.5M
- Investors: 3
- Date of first sale: 2018-02-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-327931
Issuer
- Name: ClearLight Biotechnologies, LLC
- CIK: 0001656367
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 428 OAKMEAD PARKWAY, SUNNYVALE, CA, 94085
- Phone: (800) 251-8905
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Karl Deisseroth | Director | Sunnyvale, CA |
| Albert Hansen | Director | Newport Beach, CA |
| Alex Wiegers | Director | Sunnyvale, CA |
| Laurie Goodman | Executive Officer | Sunnyvale, CA |
| John Snyder | Director | Richardson, TX |
| Sarah McCurdy | Director | Sunnyvale, CA |
| Sarah McCurdy | Executive Officer | Sunnyvale, CA |
Other filings by this issuer (2)
More